
PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) | A …
Learn about PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx), a combination treatment option for HER2-positive breast cancer that's given in minutes. See Full Safety, including most serious side effects, for more information.
What is PHESGO® (pertuzumab / trastuzumab / hyaluronidase …
What is PHESGO? PHESGO is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2+, locally advanced, inflammatory, or early stage breast cancer (tumor is …
Side Effects & Tips You Can Try - phesgo
Understand possible serious and common side effects of PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) and some tips you can try. See Full Safety, including most serious side effects, for more information.
Getting the PHESGO injection
What is PHESGO? PHESGO is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2+, locally advanced, inflammatory, or early stage breast cancer (tumor is …
What is HER2-positive Breast Cancer? - phesgo
What is PHESGO? PHESGO is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2+, locally advanced, inflammatory, or early stage breast cancer (tumor is …
Early & Metastatic Breast Cancer Treatment Schedule - phesgo
PHESGO may be one of the first treatments you get when you are diagnosed with HER2+ metastatic breast cancer. This is known as “first-line therapy,” as in, the first line of defense. PHESGO is given every 3 weeks until the cancer progresses …
Clinical trial results with PHESGO® (pertuzumab / trastuzumab ...
Understand clinical trial results of PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) compared to other HER2-positive breast cancer treatments, PERJETA® + Herceptin®. See Full Safety, including most serious side effects, for more information.
PHESGO se administra como parte de un régimen de tratamiento completo para el cáncer de mama positivo para HER2+ que incluye quimioterapia. *Su primera dosis se administra en ~8 minutos.
Important Safety Information | PHESGO® (pertuzumab / …
The most common side effects of PHESGO when given with chemotherapy as part of an early breast cancer regimen are: Hair Loss; Nausea; Diarrhea; Low levels of red blood cells; Weakness; The most common side effects of PHESGO when given with docetaxel for treatment of breast cancer that has spread to other parts of the body (metastatic) are ...
Apply for Financial Assistance for PHESGO® (pertuzumab / …
What is PHESGO? PHESGO is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2+, locally advanced, inflammatory, or early stage breast cancer (tumor is …